A detailed history of Concentric Capital Strategies, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 20,110 shares of LLY stock, worth $15.4 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
20,110
Previous 18,119 10.99%
Holding current value
$15.4 Million
Previous $16.4 Million 8.61%
% of portfolio
0.75%
Previous 0.84%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $1.54 Million - $1.91 Million
1,991 Added 10.99%
20,110 $17.8 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $9.19 Million - $11.5 Million
12,673 Added 232.7%
18,119 $16.4 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $3.23 Million - $4.31 Million
5,446 New
5,446 $4.24 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $411,660 - $567,537
947 New
947 $508,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Concentric Capital Strategies, LP Portfolio

Follow Concentric Capital Strategies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concentric Capital Strategies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Concentric Capital Strategies, LP with notifications on news.